6,485
Views
31
CrossRef citations to date
0
Altmetric
Research Paper

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway

, , , , , , , , , , & show all
Pages 6538-6558 | Received 14 Jul 2021, Accepted 24 Aug 2021, Published online: 16 Sep 2021

References

  • Liu FX, Gao X, Inglese G, et al., Overview of the Impact of Peritoneal Dialysis First or Favored Policies: an Opinion. Peritoneal Dialysis Int J Int Soc Peritoneal Dialysis. 2015;35:406–420.
  • Ali I, Chinnadurai R, Ibrahim ST, et al. Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease. BMC Nephrol. 2020;21(1): 345.
  • McCarthy JT, Moran J, Posen G, et al. A time for rediscovery: chronic hemofiltration for end-stage renal disease. Semin Dial. 2003;16:199–207.
  • Wang C, Yang C, Tang S, et al., Effects of Shengqing Jiangzhuo capsule on improvement of traditional Chinese medicine symptoms and renal function in stage 3 to 5 chronic kidney disease nondialysis patients. Hebei J Traditional Chinese Med. 2018; 40 (06): 821-826.
  • Manel V, Sergi T-M, Susana M-R, et al. Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease. Cellular Physiol Biochem Int J Exp Cellular Physiol Biochem Pharmacol. 2018;51 (3): 1287-1300.
  • Tan R, Wang C, Deng C, et al. Quercetin protects against cisplatin‐induced acute kidney injury by inhibiting Mincle/Syk/NF‐κB signaling maintained macrophage inflammation. Phytother Res. 2020;34:139–152.
  • Wu W, Yang JJ, Wan YG, et al. Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine. China J Chinese Mater Med. 2017;42:49–55.
  • Hu Y, Yan S, Liang YN, et al. Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease. Med Sci Monit. 2018;24:4760–4766.
  • Gewin L, Zent R, Pozzi A. Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int. 2017;91:552–560.
  • Tianyu Z, Liying G. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking. Bioengineered. 2021;12:2274–2287.
  • Zhou J, Zhou H, Liu C, et al. HDAC1‐mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure. J Cell Mol Med. 2020;24(15): 8636-8649.
  • Lai CY, Yang JY, Rayalam S, et al. Preventing bone loss and weight gain with combinations of vitamin D and phytochemicals. J Med Food. 2011;14:1352.
  • Guan T, Xin Y, Zheng K, et al. Metabolomics analysis of the effects of quercetin on renal toxicity induced by cadmium exposure in rats. BioMetals. 2021;34:33–48.
  • Amirshahrokhi K, Khalili A-R. Methylsulfonylmethane is effective against gastric mucosal injury. Eur J Pharmacol. 2017;811:240–248.
  • Liu W, Miao Y, Zhang L, et al. MiR-211 protects cerebral ischemia/reperfusion injury by inhibiting cell apoptosis. Bioengineered. 2020;11:189–200.
  • Patel AR, Heussen PCM, Hazekamp J, et al. Quercetin loaded biopolymeric colloidal particles prepared by simultaneous precipitation of quercetin with hydrophobic protein in aqueous medium. Food Chem. 2012;133:423–429.
  • Liu T, Tang L, Tang H, et al. Zika Virus Infection Induces Acute Kidney Injury Through Activating NLRP3 Inflammasome Via Suppressing Bcl-2. Front Immunol. 2019;10. 10.3389/fimmu.2019.01925.
  • Zhao X, Wang J, Tang L, et al. Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms. Bioengineered. 2021; 12 (1): 589-600.
  • Qin L, Chen H, Ding X, et al. Utilizing network pharmacology to explore potential mechanisms of YiSui NongJian formula in treating myelodysplastic syndrome. Bioengineered. 2021;12:2238–2252.
  • Hammoud SH, Alkhansa S, Mahjoub N, et al., Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity. Am J Physiol Renal Physiol. 2018;315:F572–F582.
  • Hammoud SH, AlZaim I, Mougharbil N, et al. Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: role of anti-diabetic drugs. Biochem Pharmacol. 2021;186:114491.
  • Su L, Huang G, Yin S, et al. A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal. BMC Ophthalmol. 2018;18:34.
  • Ye M, Hu K, Jin J, et al. The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study. BMC Nephrol. 2018;19:190.
  • Sebasky M, Kukla A, Leister E, et al. Appraisal of GFR-Estimating Equations Following Kidney Donation. Am J Kidney Dis Official J Natl Kidney Found 2009; 53:1050–1058.
  • Park J, Levin MG, Haggerty CM, et al. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes. Genet Med. 2019;22(1): 102-111.
  • Anna T, Anastasia G, Athanasios R, et al. Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy. J Diabetes Res. 2015;2015:1–8.
  • Xie YY, Zhou LP, Ye-Rong YU. A comparison of different estimation equations for glomerular filtration rate in Chinese diabetic patients. J Sichuan Univ. 2014;45:685–690.
  • Xiao Q, Guan Y, Li C, et al. Decreased expression of transforming growth factor-β1 and α-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats. Ren Fail. 2018;40:583–589.
  • Zhao K, Li Y, Wang Z, et al. Carnosine Protects Mouse Podocytes from High Glucose Induced Apoptosis through PI3K/AKT and Nrf2 Pathways. Biomed Res Int. 2019;2019:1–10.
  • Ding X, Xu X, He XF, et al. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Bioengineered. 2021;12:803–814.
  • Wu Z, Wu J, Zhao Q, et al. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol. 2020;22:631–646.
  • Moldogazieva NT, Mokhosoev IM, Terentiev AA. Metabolic heterogeneity of cancer cells: an interplay between HIF-1, GLUTs, and AMPK. Cancers (Basel). 2020;12:862.
  • Zhang Y, Chen X, Yuan L, et al. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway. Biochem Biophys Res Commun. 2018;506:529–535.
  • Dai Y, Chen Y, Wei G, et al. Ivabradine protects rats against myocardial infarction through reinforcing autophagy via inhibiting PI3K/AKT/mTOR/p70S6K pathway. Bioengineered. 2021;12:1826–1837.
  • Wang Y, Wei RB, Yang Y, et al. Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats. Med Sci Monit. 2018;24:2413–2419.
  • Yuan Z, Long C, Fau - Junming T, et al., Quercetin-induced apoptosis of HL-60 cells by reducing PI3K/Akt. 2012;Mole Biol Rep. 39:7785–7793.
  • Su W, Cao R, Zhang XY, et al. Aquaporins in the kidney: physiology and pathophysiology. Am J Physiol Renal Physiol. 2019;318(1): 193-203.
  • He J, Yang B. Aquaporins in Renal Diseases. Int J Mol Sci. 2019;20:366.
  • Li Y, Wang W, Jiang T, et al. Aquaporins in Urinary System. Adv Exp Med Biol. 2017;969:131.
  • Rump K, Adamzik M. Function of aquaporins in sepsis: a systematic review. Cell Biosci. 2018;8:10.